Viome
AI‑powered at‑home microbiome testing delivering personalized nutrition and supplement recommendations.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $250M
AI Company Overview
AI‑powered at‑home microbiome testing delivering personalized nutrition and supplement recommendations.
MicrobiomeDigestive HealthMetabolic HealthMental HealthImmune Health
Technology Platform
Metatranscriptomic sequencing combined with AI‑driven analytics to translate microbial activity into personalized health scores and recommendations.
Opportunities
Expansion into clinical reimbursement and partnerships with pharma for microbiome‑targeted therapeutics, plus growth of its supplement subscription line.
Risk Factors
Regulatory scrutiny of health claims, data‑privacy concerns, and the need for robust clinical validation to sustain consumer trust.
Competitive Landscape
Competes with DayTwo, Ombre, and other microbiome testing firms; differentiation stems from metatranscriptomic depth and AI‑driven personalized recommendations.